Home › Compare › IGF-1 LR3 vs MK-677 (Ibutamoren)
IGF-1 LR3 vs MK-677 (Ibutamoren)
IGF-1 LR3 sits in muscle / growth, while MK-677 (Ibutamoren) sits in growth hormone — so despite being mentioned together they are used for different things. A mixed vial also keeps differently: about 30 days for IGF-1 LR3 against 60 for MK-677 (Ibutamoren). The table below sets out the differences. We give no dosing guidance.
Side by side, in plain English — what each one is, where they overlap and where they genuinely differ.
IGF-1 LR3Muscle / Growth
MK-677 (Ibutamoren)Growth HormoneAt a glance
| IGF-1 LR3 | MK-677 (Ibutamoren) | |
|---|---|---|
| Category | Muscle / Growth | Growth Hormone |
| Typical route | SubQ | Oral |
| Shelf life once mixed | ~30 days | ~60 days |
| Commonly reported effects | Muscle hyperplasia Recovery Fat metabolism | Sustained GH/IGF-1 elevation Appetite increase Deeper sleep |
| Reported considerations | Hypoglycemia risk Organ growth if abused | Water retention Lethargy Insulin resistance |
The differences that actually matter
They aren't really substitutes: IGF-1 LR3 sits in Muscle / Growth while MK-677 (Ibutamoren) sits in Growth Hormone. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Route of administration differs — IGF-1 LR3 is typically subq, MK-677 (Ibutamoren) is typically oral. That alone changes how convenient each one is to keep up with.
Once reconstituted, MK-677 (Ibutamoren) keeps noticeably longer than IGF-1 LR3 (~60 days vs ~30 days), so vial waste is a real difference between the two.
Reported mainly for IGF-1 LR3: muscle hyperplasia, recovery, fat metabolism.
Reported mainly for MK-677 (Ibutamoren): sustained gh/igf-1 elevation, appetite increase, deeper sleep.
What IGF-1 LR3 is
IGF-1 LR3, or Long R3 Insulin-like Growth Factor-1, is a modified analog of native human IGF-1 designed for an extended half-life and enhanced bioavailability. It primarily exerts its effects by binding to the IGF-1 receptor, a transmembrane tyrosine kinase receptor, which then initiates intracellular signaling cascades, notably the PI3K/Akt and MAPK pathways, critical for cell growth, proliferation, and differentiation. The "LR3" modification involves an arginine substitution at position 3 and a 13 amino acid N-te
What MK-677 (Ibutamoren) is
MK-677, also known as Ibutamoren, functions as a non-peptide ghrelin receptor agonist, specifically targeting the growth hormone secretagogue receptor type 1a (GHSR-1a). By mimicking the action of endogenous ghrelin, it stimulates the pituitary gland to increase the pulsatile secretion of growth hormone (GH). This mechanism leads to sustained elevations of both GH and insulin-like growth factor 1 (IGF-1) levels in the body, typically over a 24-hour period due to its approximate 24-hour half-life. It operates by enh
How to compare them for yourself
Anecdotes online are noisy because nobody is measuring the same thing. The only comparison that means anything is your own: log each entry with a timestamp, keep the vial ledger honest so you know what you actually got through, pick two or three metrics before you start, and look at the trend after several weeks rather than day to day.
Peptide Wizard does that part for you — IGF-1 LR3 and MK-677 (Ibutamoren) are both in the built-in reference library with a 3D vial, and your history, vial ledger and cost per entry stay private on your device.
FAQ
What is the difference between IGF-1 LR3 and MK-677 (Ibutamoren)?
They aren't really substitutes: IGF-1 LR3 sits in Muscle / Growth while MK-677 (Ibutamoren) sits in Growth Hormone. People usually pick between them because of a shared secondary effect rather than because they do the same job.
Can you log IGF-1 LR3 and MK-677 (Ibutamoren) in the same period?
Plenty of people record more than one peptide at a time. Peptide Wizard keeps a separate vial ledger and entry history for each, so you can see exactly what overlapped and when — it does not recommend combinations or doses.
Which is better, IGF-1 LR3 or MK-677 (Ibutamoren)?
There isn't a universal answer — reported responses vary a lot between individuals, which is why your own log is more informative than anyone else's anecdote. Track one variable at a time and compare your own metrics over several weeks.
Is this medical advice?
No. This page is educational reference material only. It contains no dosing guidance. Speak to a qualified healthcare professional before making any decisions.
See all peptide comparisons →
Educational reference only. This page contains no dosing guidance and is not medical advice.